ImmunoChemistry Technologies, part of the Antibodies Inc. family, develops reagents, kits, and services for cell viability, apoptosis, ELISA, and immunoassay applications. Since 1994, ICT has supported researchers with reliable tools for studying cell health and building effective assays. Operating in an ISO 13485 certified facility, ICT offers a broad range of products including fluorescent cell viability assays, caspase detection kits, ELISA components, and immunohistochemistry reagents. The company also provides custom services such as assay development, conjugation, and purification. As part of Antibodies Inc., ICT complements antibody discovery and validation with functional assay solutions that support complete research workflows.
Looking for a particular ImmunoChemistry Technologies, LLC employee's phone or email?
ImmunoChemistry Technologies, LLC Questions
The ImmunoChemistry Technologies, LLC annual revenue was $7.9 million in 2026.
Kristen Pauly is the Vice President of BD and Marketing, Advisory Board Member of ImmunoChemistry Technologies, LLC.
3 people are employed at ImmunoChemistry Technologies, LLC.
ImmunoChemistry Technologies, LLC is based in Davis, California.
The NAICS codes for ImmunoChemistry Technologies, LLC are [325414, 32, 32541, 325, 3254].
The SIC codes for ImmunoChemistry Technologies, LLC are [28, 283].
Top ImmunoChemistry Technologies, LLC Employees
Related Companies
